| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |